FIA
IBB icon

FNY Investment Advisers’s iShares Biotechnology ETF IBB Stock Holding History

FNY Investment Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
+1,791
New +$308K 0.12% 188
2021
Q3 		– Sell
-200
Closed -$32K – 808
2021
Q2 		$32K Buy
+200
New +$30.8K 0.01% 491

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

FNY Investment Advisers's IBB Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,791 shares worth $340K. The stake represents 0.12% of the portfolio and ranks #188 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in IBB as recently as Q2 2021.

FNY Investment Advisers first reported a position in IBB in Q2 2021 and has held it in 2 quarters since. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • FNY Investment Advisers held 1,791 shares of iShares Biotechnology ETF worth $340K as of Q2 2026.
  • iShares Biotechnology ETF was a new FNY Investment Advisers position in Q2 2026.
  • iShares Biotechnology ETF made up 0.12% of FNY Investment Advisers's portfolio in Q2 2026, its #188 holding.
  • FNY Investment Advisers first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 2 quarters since.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.